Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CTIT: Cancer Therapy Induced Thrombocytopenia”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Large-scale testing (Phase 3)Looking for participantsNCT06759636
What this trial is testing

A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11

Who this might be right for
CTIT: Cancer Therapy Induced Thrombocytopenia
The First Affiliated Hospital with Nanjing Medical University 88
Testing effectiveness (Phase 2)Looking for participantsNCT07441720
What this trial is testing

Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)

Who this might be right for
ThrombocytopeniaCancer Treatment-induced Thrombocytopenia
Zhejiang Cancer Hospital 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07252375
What this trial is testing

A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)CTIT-Chemotherapy Induced Thrombocytopenia
Fujian Cancer Hospital 35
Testing effectiveness (Phase 2)Looking for participantsNCT06898983
What this trial is testing

Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Leukemia

Who this might be right for
Cancer Treatment-induced Thrombocytopenia (CTIT)
Anhui Provincial Hospital 97
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07334093
What this trial is testing

Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.

Who this might be right for
Cancer Therapy-induced Thrombocytopenia (CTIT)
Sun Yat-sen University 204
Not applicableNot Yet RecruitingNCT07185893
What this trial is testing

A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors

Who this might be right for
Solid Tumor Malignancies, CancerCTIT-Chemotherapy Induced ThrombocytopeniaThrombocytopenia
Jun wang 106
Early research (Phase 1)Looking for participantsNCT07110090
What this trial is testing

Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)

Who this might be right for
ThrombocytopeniaCancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 16
Post-approval studies (Phase 4)UnknownNCT05411705
What this trial is testing

Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury

Who this might be right for
Cancer Treatment Induced Thrombocytopenia
The First Affiliated Hospital of Dalian Medical University 165
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07647029
What this trial is testing

A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced Thrombocytopeniae

Who this might be right for
Breast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT)
Fudan University 126